Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511735200 on February 28, 2006

J. Biol. Chem., Vol. 281, Issue 26, 17559-17569, June 30, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/26/17559    most recent
M511735200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoufias, D. A.
Right arrow Articles by Kozielski, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoufias, D. A.
Right arrow Articles by Kozielski, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

S-Trityl-L-cysteine Is a Reversible, Tight Binding Inhibitor of the Human Kinesin Eg5 That Specifically Blocks Mitotic Progression*Formula

Dimitrios A. Skoufias{ddagger}, Salvatore DeBonis§, Yasmina Saoudi, Luc Lebeau||, Isabelle Crevel**, Robert Cross**, Richard H. Wade§, David Hackney{ddagger}{ddagger}, and Frank Kozielski§1

From the {ddagger}Laboratoire des Protéines du Cytosquelette and §Laboratoire de Moteurs Moléculaires, Institut de Biologie Structurale (Commissariat à l'Energie Atomique-CNRS-UJF), 41 Rue Jules Horowitz, 38027 Grenoble Cedex 01, France, Laboratoire du Cytosquelette, INSERM Unite 366, Commissariat à l'Energie Atomique, 38054 Grenoble Cedex 9, France, ||Laboratoire de Chimie Organique Appliquée, Institut Gilbert-Laustriat, CNRS, Université Louis Pasteur, Faculté de Pharmacie, 74 Route du Rhin, 67401 Illkirch Cedex, France, **Marie Curie Research Institute, Oxted RH8 0TL, United Kingdom, and the {ddagger}{ddagger}Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213

Human Eg5, responsible for the formation of the bipolar mitotic spindle, has been identified recently as one of the targets of S-trityl-L-cysteine, a potent tumor growth inhibitor in the NCI 60 tumor cell line screen. Here we show that in cell-based assays S-trityl-L-cysteine does not prevent cell cycle progression at the S or G2 phases but inhibits both separation of the duplicated centrosomes and bipolar spindle formation, thereby blocking cells specifically in the M phase of the cell cycle with monoastral spindles. Following removal of S-trityl-L-cysteine, mitotically arrested cells exit mitosis normally. In vitro, S-trityl-L-cysteine targets the catalytic domain of Eg5 and inhibits Eg5 basal and microtubule-activated ATPase activity as well as mant-ADP release. S-Trityl-L-cysteine is a tight binding inhibitor (estimation of Ki,app <150 nM at 300 mM NaCl and 600 nM at 25 mM KCl). S-Trityl-L-cysteine binds more tightly than monastrol because it has both an ~8-fold faster association rate and ~4-fold slower release rate (6.1 µM–1 s–1 and 3.6 s–1 for S-trityl-L-cysteine versus 0.78 µM–1 s–1 and 15 s–1 for monastrol). S-Trityl-L-cysteine inhibits Eg5-driven microtubule sliding velocity in a reversible fashion with an IC50 of 500 nM. The S and D-enantiomers of S-tritylcysteine are nearly equally potent, indicating that there is no significant stereospecificity. Among nine different human kinesins tested, S-trityl-L-cysteine is specific for Eg5. The results presented here together with the proven effect on human tumor cell line growth make S-trityl-L-cysteine a very attractive starting point for the development of more potent mitotic inhibitors.


Received for publication, October 31, 2005 , and in revised form, February 15, 2006.

* This work was supported by Contract 5197 from Association pour la Recherche sur le Cancer, Alliance Des Recherches sur le Cancer, and Contracts 03 013690 02 and 03 013690 01 from the Région Rhône-Alpes. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2 and Movies S1 and S2.

1 To whom correspondence should be addressed: Institut de Biologie Structurale, 41 Rue Jules Horowitz, 38027 Grenoble, France. Tel.: 33-4-3878-4024; Fax: 33-4-3878-5494; E-mail: Frank.kozielski{at}ibs.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCBHome page
A. D. Silk, A. J. Holland, and D. W. Cleveland
Requirements for NuMA in maintenance and establishment of mammalian spindle poles
J. Cell Biol., March 9, 2009; 184(5): 677 - 690.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J.-H. Wei and J. Seemann
The mitotic spindle mediates inheritance of the Golgi ribbon structure
J. Cell Biol., February 9, 2009; 184(3): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C.-K. Hu, M. Coughlin, C. M. Field, and T. J. Mitchison
Cell polarization during monopolar cytokinesis
J. Cell Biol., April 21, 2008; 181(2): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. K. Famulski, L. Vos, X. Sun, and G. Chan
Stable hZW10 kinetochore residency, mediated by hZwint-1 interaction, is essential for the mitotic checkpoint
J. Cell Biol., February 6, 2008; 180(3): 507 - 520.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. A. Skoufias, R.-L. Indorato, F. Lacroix, A. Panopoulos, and R. L. Margolis
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed
J. Cell Biol., November 19, 2007; 179(4): 671 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement